Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

Clinical trial NCT05078047 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05078047
Sponsor: UNICANCER
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Cancer Metastatic Renal Cell Carcinoma Head and Neck Cancer Triple Negative Breast Cancer Merkel Cell Carcinoma Hepatocellular Carcinoma Melanoma Urothelial Carcinoma Colorectal Carcinoma With Microsatellite Instability Esophageal Squamous Cell Carcinoma Endometrial Carcinoma Cervical Cancer

Start date: 2022-03-08
Primary completion: 2029-05-07
Enrollment: 646

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.